Introduction
Mitogen-activated protein kinases (MAPKs), also known as extracellular signal-regulated kinases, are proteinserine/threonine kinases that are rapidly activated upon stimulation of a variety of cell surface receptors (Ray and Sturgill, 1987) . Their function is to convert extracellular stimuli to intracellular signals controlling the expression of genes essential for many cellular processes, including cell growth and differentiation (Marshall, 1995) . These kinases play a central role in mitogenic signaling, as impeding their function prevents cell proliferation in response to a number of growth-stimulating agents (Pages et al., 1993) . Furthermore, aberrant functioning of proteins known to be upstream of MAPK can induce cells to acquire the transformed phenotype, and constitutive activation of the MAPK pathway is itself sufficient for tumorigenesis Mansour et al., 1994) . Thus, MAPKs appear to be a critical component of growth-promoting pathways.
Recently, two novel classes of mammalian enzymes closely related to MAPKs have been identified. One class presents extended similarity to the Saccharomyces cerevisiae HOG1 kinase (Han et al., 1994) , which is involved in protecting S. cerevisiae from hyperosmotic solutions (reviewed by Herskowitz, 1995) . The role of this mammalian HOG1 homolog is largely unknown. Although it can also be activated by changes in osmolarity, it appears to participate in the inflammatory response to lipopolysaccharides or to inflammatory mediators such as interleukin-1 (IL-1) (Han et al., 1994; Freshney et al., 1994) . The other class of MAPKs represents a family of closely related enzymes activated by cellular stress, which have been named stress-activated protein kinases (SAPKs) . SAPKs were independently identified by virtue of their ability to phosphorylate the amino terminus of the c-Jun transcription factor; hence, they have been also termed c-Jun amino-terminal kinases (JNKs) (D~rijard et al., 1994) . JNKs can be potently activated by inhibitors of protein synthesis such as cycloheximide and anisomycin, inflammatory cytokines such as tumor necrosis factor (TNFa) and IL-1, changes in osmolarity, heat shock, and ultraviolet irradiation (D6rijard et al., 1994; Kyriakis et al., 1994) . JNKs are thought to be responsible for phosphorylating the transactivating domain of c-Jun protein in vivo Kyriakis et al., 1994) , and, in turn, phosphorylated c-Jun homodimers have potent AP-1 activity and can control the expression of a number of genes, including c-jun itself (Angel et al., 1988) . The mechanism of activation of JNKs has just begun tO be explored. Although initial observations suggested that these enzymes were located downstream of Ras (D6-rijard et al., 1994) , this hypothesis is in conflict with recently available data (Sun et al., 1994) , including'the lack of activation of JNK in certain cellular systems by agonists acting on receptors that are known to couple to the Ras-MAPK pathway Coso et al., 1995) . Furthermore, agonists such as TNFa and IL-1 potently induce JNK, but they activate MAPK poorly . Taken together, these observations suggest the existence of distinct pathways leading to the activation of either MAPK or JNK. In this study, we have used the expression of hemagglutinin (HA) epitope-tagged JNK1 (HA-JNK) in COS-7 cells to explore the mechanism of activation of J N K. We present evidence that the small GTP-binding proteins Racl and Cdc42 are an integral part of a novel signaling pathway linking cell surface receptors to JNK activation.
Results

Functional Expression of an Epitope-Tagged JNK
The JNK1 cDNA was obtained by the polymerase chain reaction (PCR)technique, its coding sequence was altered by the insertion of an amino-t~rminal tag of 9 amino acids representing influenza HA1 protein (Wilson et al., 1984) , and the cDNA was cloned in the expression vector pcDNA3. As shown in Figure 1 Lysates containing 40 l~g of protein from COS-7 cells transfected with pcDNA3 vector (control) or with an expression plasmid carrying an epitope-tagged human JNK1 cDNA (HA-JNK) (1 ~g per plate) were subjected to Western blot (WB) analysis with antibodies against HA or JNK1, as indicated. Additional lysates containing 800 pg of cellular protein were first i mmunoprecipitated with the anti-HA antibody (HA-IP) and then subjected to the same analysis. Bands were visualized by ,.4he enhanced chemiluminescence technique using the appropriate horseradish peroxidase-conjugated goat antiserum. Arrows indicate the position of the epitope-tagged J NK1 protein. Parallel immunoprecipitates from serum-starved cells untreated (minus) or exposed to anisomycin (10 l~g/ml; 20 min) (plus) were assayed for JNK activity (JNK) ~;~ described in Experimental Procedures, using GST-c-Jun(79) or GST-ATF2(96) as substrates. Bands corresponding to the radiolabeled substrate are indicated.
(HA-JNK) was efficiently expressed when transfected into COS-7 cells, as judged by its immunodetection with the anti-HA murine monoclonal antibody 12CA5 (Wilson et al., 1984) or with a JNKl-specific antiserum. Furthermore, only HA-JNK-transfected cells exhibited in vitro phosphorylating activity in an immunocomplex kinase assay, using purified glutathione S-transferase (GST)-c-Jun(79) or GST-ATF2(96) as substrates (Figure 1, bottom) . Exposure of serum-starved cells to anisomycin, a potent JNK/SAPK activator , induced a striking increase in JNK activity (Figure 1, bottom) . Thus, this epitope-tagged JNK1 encoded by the HA-JNK cDNA construct functions as a JNK.
Activation of JNK Involves a Signaling Route Different from That of the Ras-MAPK Pathway
Although a number of studies have demonstrated that the activity of c-Jun and JNK is elevated in cells transformed by oncogenic ras genes (Angel and Karin, 1991; D~rijard et al., 1994; Westwick et al., 1994) , many growth factors known to activate the Ras-MAPK pathway fail to elevate the enzymatic activity of JNK in several cellular systems Coso et al., 1995 Hall, 1994) . Thus, we engineered expression vectors for representative members of these subfamilies, including RhoA, Racl, and Cdc42, and their corresponding activated mutants. The latter were generated by replacing glutamine for leucine in RhoA, Racl, and Cdc42 (QL mutants) in a position analogous to that of codon 61 of Ras. Such a mutation has been shown to inhibit the GTPase activity of most of these proteins (Bourne et al., 1991) . When transfected into COS-7 cells, RhoA, Racl, and Cdc42 were detectably expressed, as judged by GTPase-specific antibodies ( Figure 3C ). However, these GTP-binding proteins failed to activate MAPK, although v-ras had a very potent effect under the same experimental conditions ( Figure 3A ). In contrast, Rho-related GTPases effectively activated JNK, although to a variable extent ( Figure 3B (Hart et al., 1991 (Hart et al., , 1994 Horii et al., 1994) , induce in vitro the exchange of GDP for GTP on RhoA and Cdc42 have suggested that these oncogenes can activate in vivo both small GTP-binding proteins. In view of our results, we next examined whether expression of db/and ost can induce JNK activity in COS-7 cells. We constructed expression plasmids for the ost (Horii et al., 1994) and the dbl oncogene (onc-db/) and for the db/protooncogene (proto-db/) (Ron et al., 1988) . As a control, we also expressed the catalytic domain (Cdc25 domain) of SOS, a guanine nucleotide exchang~factor (GEF) for Ras (Chardin et al., 1993) , upon targeting to the plasma membrane by fusing its coding sequence to that of the aminoterminal myristoylation signal from c-Src (Takeya and Hanafusa, 1983) . As expected, when expressed in COS-7 cells, the myristoylated Cdc25 domain of SOS was localized to the plasma membrane fraction (data not shown) and potently induced MAPK (Figure 4 ), but it had little effect on JNK. In contrast, transfection of COS-7 cells with expression vectors carrying the cDNA for the ost, onc-dbl, or proto-dbloncogene did not affect MAPK functioning, but induced a remarkable increase in JNK enzymatic activity, Which was nearly as great as that caused by exposing cells to anisomycin ( Figure 4 ). Therefore, we conclude that Racl and Cdc42 Rho-like GTP-binding proteins and their exchange factors can effectively induce pathways leading to the activation of JNK. Thus, expression of inhibiting molecules for Rho-like proteins blocks JNK activation by oncogenic exchange factors, but does not prevent coupling of constitutively active forms of Racl and Cdc42 to their downstream targets. Interestingly, molecules inhibiting Rho-like GTPases also blocked the activation of JNK by v-ras ( Figure 5 ). In contrast, they had nearly no effect on v-ras-induced MAPK activation ( Figure 5 ). This observation further demonstrates the specificity of this experimental approach and raises the possibility of the existence of a pathway commu-nicating Ras with the Rho family of small GTP-binding proteins.
We next examined the effect of RhoGDI and RhoGAP proteins on JNK activation in response to agonists acting through receptors endogenously expressed in COS-7 cells. We initially found that TNFa (10 p.g/ml) and epidermal growth factor (EGF) (100 ng/ml) were both able to activate JNK ( Figure 5 ). As shown in Figure 5 , coexpression of inhibiting molecules for Rho-related proteins potently blocked stimulation of JNK by both agonists, but they had little effect on the JNK activity induced by anisomycin when used as a control. In contrast, RhoGDI, RhoGAPd p190, and myr RhoGAPd p190 did not significantly affect the MAPK response to EGF ( Figure 5 ). Thus, inhibitory proteins for Rho-related GTPases selectively prevent coupling of TNFa and EGF receptors to the JNK pathway.
Dominant Negative Mutants of Racl and Cdc42
Inhibit Signaling from Cell Surface Receptors to JNK To determine which Rho-related GTPase participates in signaling to JNK, we have made use of dominant negative mutants for RhoA, Racl, and Cdc42. In each case, we replaced threonine for asparagine in a position analogous to codon 17 of Ras, thus generating N19RhoA, N17Rac1, and N17Cdc42, respectively. By analogy to the activity of N17Ras, these inhibitory mutants are thought to act by competitively inhibiting the interaction of endogenous GTP-binding proteins with their respective G EFs (Feig and Cooper, 1988) . When transfected into COS-7 cells, each mutated GTPase was found to be detectably expressed (data not shown). We next examined the ability of N 19RhoA, N17Racl, and N17Cdc42 to affect JNK activation by stressinducing agents or by agonists acting on cell surface receptors. As shown in Figure 6 , none of these inhibitory mutants affected the JNK response to anisomycin. In contrast, expression of N17Rac1 and N17Cdc42 potently blocked the JNK activation elicited by EGF (Figure 6 ), but did not affect the MAPK response to this growth factor (data not shown). N17Racl and N17Cdc42 also diminished JNK stimulation produced by TNFa (Figure 6 ). However these mutated GTPases were less effective as blockers than the inhibitory proteins utilized in the experiments shown in Figure 5 , thus raising the possibility that additional GTP-binding proteins might also participate in signaling from TNFa receptor to JNK. In addition, neither N19RhoA, N17Rac1, nor N17Cdc42 had any demonstrable effect on JNK stimulation by Racl-QL and Cdc42-QL, th us suggesting that each GTPase can cou pie to the downstream effector(s) in an independent manner.
We also examined whether Ras plays a role in signaling JNK activation by extracellular stimuli, using a dominant negative mutant of Ras (N17Ras) (Feig and Cooper, 1988) . We found that the JNK response to TNFm anisomycin, Racl-QL, and Cdc42-QL was not affected by N 17Ras, but that this molecule abolishes signaling from EGF receptors to both JNK and MAPK ( Figure 6 ; Crespo et al., 1994) . Thus, taken together these findings demonstrate that tyrosine kinase receptors require functioning of Ras and Racl, Cdc42, or both to activate JNK. (1 lig per plate) (bars 5) together with pcDNA3-HA-J NK. Serum-starved cells were stimulated with EGF (100 ng/ml; 15 rain), TNF~ (10 i~g/ml; 15 min), or anisomycin (10 p~g/ml; 20 rain), as indicated, and processed for immunocomplex JNK assays as described in Figure 2 . Data represent the mean _+ SEM of three to five independent experiments, expressed as fold increase with respect to vector-transfected cells (control).
Discussion
A large number of extracellular stimuli can potently activate JNK, including inflammatory cytokines, certain growth factors, G protein-coupled receptors, protein synthesis inhibitors, changes in osmolarity, ultraviolet light, et cetera Kyriakis et al., 1994; Coso et al., 1995) . Many of these agents also weakly activate MAPKs. Conversely, potent MAPK stimulants such as phorbol esters and growth-promoting agents acting on tyrosine kinase receptors fail to activate JNK in a number of cell types Coso et al., 1995) . Thus, the emerging picture is that JNK is regulated independently of MAPKs. In this regard, expression of constitutively active oncogenic forms of ras has been shown to induce MAPK potently but to raise JNK phosphorylating activity to a much more limited extent Sun et al., 1994) . In line with these observations, transient expression of v-ras in COS-7 cells potently activated an epitope-tagged MAPK (Crespo et al., 1994 ; this study), but had little effect on an epitope.tagged JNK. Furthermore, constitutively activated forms of molecules connecting Ras to MAPK dramatically activated MAPK, but did not have any demonstrable effect on JNK. Under the same experimental conditions, exposure of cells to a protein synthesis blocker, anisomycin, elicited a marked increase of JNK activity, but weakly stimulated the epitope-tagged MAPK. Thus, our results in COS-7 cells are consistent with those recently reported in NIH 3T3 (Yan et al., 1994) , HeLa, and PC12 cells (Minden et al., 1994) and provide compelling evidence that the pathway communicating Ras to JNK is different from that controlling MAPKs. These observations raise the possibility that proteins other than Ras may directly regulate biochemical pathways leading to the activation of JNK. In this regard, the Ras superfamily of GTPases comprises more than 50 members, which have been divided into six families based upon sequence similarity: Rab, Arf, Sar, Ran, Rho, and Ras (see Lamarche and Hall, 1994) . Whereas the Rab, Arf, and Sar groups have been shown to participate in the transport of proteins and vesicles among different intracellular compartments (Boguski and McCormick, 1993; Hall, 1994) , the Ras family is involved in growth control (see below). The Rho family of GTP-binding proteins consists ~f the Rho, Rac, and Cdc42 subfamilies and has been shown to regulate several aspects of cytoskeleton functioning (reviewed by Hall, 1994) . The Rho subfamily has at least four members, RhoA, RhoB, RhoC, and RhoG. RhoA has been shown to participate in the formation of actin stress fibers, as well as in mediating redistribution of cytoskeletal components Hall, 1994) . The Rac subfamily includes Racl and Rac2, and Racl has been shown to be involved in membrane ruffling . The Cdc42 group consists of Cdc42Hs (referred to here as Cdc42) and G25K (see Hall, 1994) , and its function in mammalian cells is still largely unknown. Ras has been shown to play a central role in cell proliferation and differentiation. At the molecular level, Ras exchanges GDP for GTP upon activation of Ras-specific GEFs, and in the GTP-bound state, Ras physically associates with the amino-terminal domain of Raf (Vojtek et al., 1993) . This process recruits Raf to the plasma membrane, allows the activation of Raf by a still unknown mechanism (see McCormick, 1994) , and initiates a sequential cascade of kinases leading to MAPK activation. Interestingly, it has been recently reported that GTP-bound forms of the Rhorelated proteins Racl and Cdc42 can specifically associate and activate a novel serine/threonine kinase, the p21-activated kinase (PAK) (Manser et al., 1994) . This situation is highly analogous to that of the Ras-Raf interaction, thus suggesting that the Rho family of GTP-binding proteins might also initiate activity of a kinase cascade (Manser et al., 1994) . This observation and the failure of Ras fully to activate JNK prompted us to ask whether the Rho family of GTPases participates in signaling to the JNK pathway.
Our findings demonstrate that expression of activated forms of Racl and Cdc42 can efficiently stimulate JNK without affecting MAPK activity. Interestingly, although activated RhoA is known to induce the most dramatic changes in the cytoskeletal structure ; data not shown), it stimulates JNK very poorly. Furthermore, we have found that treatment of cells with cytoskeletal-disrupting agents such as cytochalasin D fails to block JNK activation induced by Racl and Cdc42 (our unpublished data). We conclude that Racl and Cdc42 can effectively stimulate signaling pathways leading to JNK activation, probably through a mechanism distinct from that involved in cytoskeletal reorganization.
The functioning of Rho-like GTP-binding proteins is tightly regulated in vivo by proteins that control their GDP/ GTP state. GAPs (reviewed by Lamarche and Hall, 1994) and GDIs are negative modulators, whereas GEFs (Boguski and McCormick, 1993) promote the exchange of GDP for GTP, thus activating Rho-like proteins. Based upon our results, we asked whether GEFs for Rho-related GTPases were also capable of inducing JNK activity. Two GEFs for this family have been described: the protein products of the ost and onc-dbl oncogenes (Hart et al., 1991 ; Horii et al., 1994) . Our data demonstrate that both exchange factors for Rho-like proteins can potently induce JNK activity. In addition, it was noticeable that both oncogenic exchange factors poorly induced MAPK in COS-7 cells, similar to that previously reported for dbl and vav in NIH 3T3 cells (Khosravi-Far et al., 1994) . Conversely, we have observed that a plasma membranetargeted catalytic (Cdc25-1ike) domain of SOS greatly induces MAPK, but has a minimal effect on JNK. Taken together, these data provide additional evidence that molecules activating the Ras pathway preferentially stimulate MAPKs and establish that proteins acting on Rho-related GTPases can efficiently signal to JNK.
A number of RhoGAPs have been identified and have been shown to display variable specificity with respect to their activity on each member of the Rho family (Lamarche and Hall, 1994) . For example, RhoGAPd p190, a RasGAPassociated protein (Settleman et al., 1992a) , can stimulate in vitro the GTPase activity of RhoA, Racl, and Cdc42 to a comparable extent (Lamarche and Hall, 1994) . RhoGDI forms a cytosolic complex preferentially with GDP-bound forms of RhoA, Racl, and Cdc42 Sasaki et al., 1993; Hall, 1994) , thus preventing their activation. Both GAPs and GDIs have proven to be useful tools for blocking the function of Rho-related GTPases in a variety of biological systems (Ridley et al., 1993; Nishiyama et al., 1994; Hall, 1994) ; thus, we utilized their expression as a simple approach to investigate a role for Rho-related proteins in the JNK signal transduction pathway. Here, we show that expression of RhoGDI and RhoGAPd p190 as well as a mem brane-targeted RhoGAPd p 190 (myr RhoGAPd p190) effectively block JNK activation by ost and dbl. In contrast, these inhibitory molecules for Rho-related GTPases failed to block JNK stimulation by the mutationally activated Cdc42. This observation is consistent with the finding that RhoGDI poorly associates with GTPbound proteins of the Rho family (Sasaki et.al., 1993) and with the lack of effect of GAPs on mutationally activated proteins of the Ras superfamily .
It also demonstrates that neither RhoGDI nor RhoGAPd p190 exerts a direct inhibitory effect on JNK. In addition, Rho-blocking proteins prevented JNK activation by v-ras, EGF, and TNFa, but did not affect signaling from EGF receptors or v-ras to MAPK. These findings further support the specificity of this approach and provide strong evidence that Ras, as well as EGF and TNFa receptors, signals to JNK through Rho-related GTPases.
To establish the identity of the endogenously expressed GTP-binding protein(s) that participates in linking cell surface receptors to JNK, we made use of dominant negative mutants for each class of GTPases, Ras, RhoA, Racl, and Cdc42. We found that the dominant negative mutant of Ras effectively prevents MAPK (Crespo et al., 1994) and JNK activation by EGF, but not JNK stimulation induced by either TNF~ or anisomycin. Thus, functioning of Ras appears to be strictly required for linking EGF receptors to JNK, whereas other stimuli utilize Ras-independent pathways. In this regard, we have found that the dominant negative mutants of Racl and Cdc42 effectively reduce JNK stimulation elicited by both EGF and TNFm suggesting that the pathway connecting TNF~ and EGF receptors to JNK involves Racl and Cdc42 or, alternatively, a common GEF acting on either GTPase. Thus, taking the inhibitory action of N 17Rac1 and N17Cdc42, the blockade of JNK activation upon expression of negative regulators of Rho-related proteins, and the pattern of JNK stimulation by mutationally activated GTPases, we conclude that the small GTP-binding proteins Racl and Cdc42 are an integral part of the biochemical route linking cell SUrface receptors to JNK.
The JNK response to anisomycin was not affected by inhibitors of Rho-related proteins, nor by N17Rac1 or N17Cdc42, thus suggesting that cell-stressing stimuli might induce JNK activity independently of these GTPbinding proteins. On the other hand, expression of the inhibitory mutants of RhoA, Racl, or Cdc42 did not affect JNK stimulation by constitutively activated Racl and Cdc42, which is not consistent with the existence of a hierarchically arranged cascade of GTPases, as recently reported for cytoskeletal regulation Nobes and Hall, 1995) . Instead, these results strongly suggest that each GTPase, Racl and Cdc42, can activate effector pathways independently. Whether PAK or a PAK-related kinase, which can bind either Racl or Cdc42, is immediately downstream of these GTPases in the biochemical route to JNK warrants further investigation.
The emerging picture from our study and from recent reports (Minden et al., 1994; Sanchez et al., 1994; Yan et al., 1994; D~rijard et al., 1995) is that mammalian cells have independent signaling pathways connecting cell surface receptors with each member of the MAPK superfamily. This situation is remarkably similar to that of the budding yeast S. cerevisiae, in which genetic studies have revealed the existence of parallel cascades of kinases leading to the activation of at least three distinct MAPKrelated enzymes (reviewed by Herskowitz, 1995) . In the case of the mating pheromone response, extracellular ligands (~ or a factors) activate cell surface receptors that in turn induce the dissociation of a heterotrimeric G protein into a (GPA1) and I~' (Ste4 and Ste18) subunits (reviewed by Bardwell et al., 1994; Herskowitz, 1995; see Figure 7) . Free J37 dimers then activate a serine/threonine kinase, Ste20 initiating activity from a linear cascade of kinases, including, sequentially, Stel 1 and Ste7, which phosphorylate and activate the yeast MAPK homologs Fus3 and Kssl ( Figure 7 ). As discussed above, JNK and MAPK are highly related to each other and to the budding yeast MAPKs. Four mammalian homologs of Ste7 have been identified, two of them (MEK1 and MEK2) specifically activate MAPK (Crews et al., 1992) , and one (designated SEK [Sanchez et al., 1994] Herskowitz, 1995) . In the mammalian MAPK pathway, only three levels have been identified, represented by MAPK, MEK, and Raf (see Marshall, 1995) . In the mammalian JNK signaling route, JNK, SEK, and MEKK represent the first three hierarchical levels (see text for details), and we postulate that PAK (Manser et al., 1994 ) or related enzymes represent the most upstream kinase in this cascade.
Whether that is the case remains to be established. Activity of these kinase cascades is tightly regulated. Ras controls mammalian MAPK by acting directly on Raf. Our study has shown that the small GTPbinding proteins Racl and Cdc42 regulate the JNK pathway. Rhorelated GTPases have been previously suggested to regulate the activity of budding yeast Ste20 or of its newly identified homologous proteins (see Bardwell et al. 1994) , although biochemical evidence is still missing. Broken lines represenl potential cross-talks among signaling systems. The pathway connecting cell surface receptors to low molecular weight GTP-binding proteins and the identity of biologically relevant targets ,for these kinase cascades are yet to be fully elucidated.
functional homologs of Ste11 are Raf and MEK kinase (MEKK) (Lange-Carter et al., 1993) . Raf is located upstream of MEK, thus defining a linear kinase cascade represented by the Raf-MEK-MAPK signaling module, whose activity is dependent on Ras (see above). MEKK is closely related to Stel 1 by primary sequence similarity, and two different groups have recently observed that MEKK functions preferentially in the JNK pathway, specifically controlling SEK activity (Yan et al., 1994; Minden et al., 1994) . The identity of molecules that directly regulate MEKK is still unknown, in this regard, a mammalian homolog of Ste20 has been recently isolated, p65 pAK (Manser et al., 1994) , and it has been shown that Ste20 and PAKs are activated upon interaction with GTP-bound forms of Racl and Cdc42. Taken together, these observations and our present results demonstrating that Racl and Cdc42 can regulate the activity of JNK enable us to postulate that either PAK or related kinases link Racl and Cdc42 to the MEKK-SEK-JNK module (Figure 7 ). Such a hypothesis linking small GTP-binding proteins of the Rho family to the JNK signaling pathway is testable and will be the target for future investigation.
Experimental Procedures
~ Expression Plasmids JNK1 cDNA (D~rijard et al., 1994) was obtained by the PCR technique using as a template human skeletal muscle cDNA (Invitrogen) and was cloned into the Bglll and Sail sites of pcDNA3-HA, a modified pcDNA3 expression plasmid (Invitrogen) encoding the HA nonapeptide epitope (Wilson et al., 1984 ; J. S. G., unpublished data). The previously described cDNAs for human RhoA, Racl, and Cdc42Hs (referred to in this paper as Cdc42) GTP-binding proteins (Horii et al., 1994) were cloned in pcDNA3 as BamHI-EcoRI fragments. Their respective constitutively activated mutants were obtained by replacing a glutamine residue corresponding to codon 63 of RhoA or codon 61 of Ract and Cdc42 for a leucine residue (QL mutants), using PCR-directed mutagenesis. Dominant negative mutants for each small GTP-binding protein were obtained by replacing threonine for asparagine in a position analogous to codon 17 of Ras, generating N19RhoA, N17Rac1, and N17Cdc42.
Wild-type MEK1 (Crews et al., 1992) (provided by R. Erickson) was cloned into the pcDNA3 vector as a BamHI-Notl fragment. Activated MEK1 was generated by replacing Ser-218 and Ser-222 by glutamic acid; this construct was designated MEKEE . A f .4 kb DNA fragment encoding the Cdc25 domain of the human SOS protein (codons 568-1042) was amplified by PCR using human SOS cDNA (Chardin et al., 1993) as a template and was subcloned into pcDNA3-myr, a modified pcDNA3 expression plasmid encoding the amino-terminal 21 amino acids of chicken c-Src (Takeya and Hanafusa, 1983) , which includes the c-Src amino-terminal myristoylation signal (H. T. and J. S. G., unpublished data). Onc-dbl and proto-dbl cDNAs Ron et aL, 1988) were subcloned as BamHI fragments in the pcDNA3 expression vector. A 1.1 kb DNA fragment encoding the RhoGAP domain of human p190 protein associated to RasGAP (Settleman et al., 1992b ) (codons 1177-1512) was amplified by PCR using rat brain cDNA and appropriate oligonucleotides and was subcloned into pcDNA3-KZ, a modified pcDNA3 vector containing an efficient translational initiation sequence as described by Kozak (1989) upstream of an artificial initiation codon in-frame with the BamHI site (O. A. C. and J. S. G., unpublished data) or pcDNA3-myr (see above). RhoGDI (Fukumoto et al., 1990 ) (provided by Y, Takai) was subcloned as a BamHI-EcoRI fragment into the pcDNA3-KZ vector. In all cases, nucleotide sequences of wild-type and mutated cDNAs were verified by DNA sequencing. The sequence of oligonucleotides utilized for each DNA construct will be made available upon request,
Kinase Assays
JNK Assay
Subconfluent COS-7 cells were transfected with pcDNA3-HA-JNK and additional DNAs by the DEAE-dextran technique. Total amount of plasmid DNA was adjusted to 5-10 p.g per plate with vector DNA (pcDNA3; Invitrogen) when necessary, and 2 days later, transfected COS-7 cells were cultured overnight in serum-free medium. Cells were then left untreated or stimulated with various agents, washed with cold PBS, and lysed at 4°C in a buffer containing 25 mM HEPES (pH 7.5), 0.3 M NaCI, 1.5 mM MgCI2, 0.2 mM EDTA, 0.5 mM D'l-r, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 20 mM ~-glycemphosphate, 1 mM sodium vanadate, 1 mM phenyimethylsulfonyifluoride, 20 p.g/ml aprotinin, and 20 pg/ml leupeptin. The epitope-tagged JNK was immunoprecipitated from the cleared lysates by incubation with the specific antibody 12CA5 (BABCO) for 1 hr at 4°C. Immunocomplexes were recovered with the aid of Gamma-Bind 8epharose beads (Pharmacia) and washed three times with PBS containing 1% NP-40 and 2 mM sodium vanadate, once with 100 mM Tris (pH 7.5), 0.5 M LiCI, and once with kinase reaction buffer (12.5 mM MOPS [pH 7.5], 12.5 mM ~-glycerophosphate, 7.5 mM MgCI2, 0.5 mM EGTA, 0.5 mM sodium fluoride, 0.5 mM sodium vanadate). The JNK activity present in the immunoprecipitates was determined by resuspension in 30 p.I of kinase reaction buffer containing 1 i~Ci of [~,-~P]ATP per reaction and 20 pM unlabeled ATP, using 1 p.g of GST-c-Jun(79) or GST-ATF2(96) fusion protein as a substrate, as previously described (Coso et al., 1995) . After 20 rain at 30°C, reactions were terminated by addition of 10 pl of 5x Laemmli's buffer. Samples were heated at 95°C for 5 rain and analyzed by SDS electrophoresis on 12% polyacrylamide gels. Autoradiography was performed with the aid of an intensifying screen. Parallel anti-HA immunoprecipitates were processed for Western blot analysis using a JNK-specific antiserum.
MAPK Assay
MAPK activity in COS-7 cells transfected with an epitope-tagged MAPK (HA-ERK2, referred to here as HA-MAPW) was determined as previously described (Crespo et al., 1994) , using myelin basic protein as a substrate. Parallel samples were immunoprecipitated with anti-HA antibody and processed for Western blot analysis using a MAPKspecific antiserum.
Western Blots
• Lysates containing approximately 40 p~g.of total cellular protein or anti-HA immunoprecipitates were analyzed by Western blotting after SDS-polyacrylam ide gel electrophoresis, transferred to nitrocelldlose, and immunoblotted with the corresponding rabbit antiserum or mouse monoclonal antibody. Immunocomplexes were visualized by enhanced chemiluminescence detection (Amersham) using goat antirabbit or anti-mouse antiserum coupled to horseradish peroxidase as a secondary antibody (Cappel). Mouse monoclonal antibodies anti-HA epitope clone 12CA5 and anti-p190 were purchased from BABCO and from Transduction Laboratories, respectively. Rabbit polyclonal antisera anti-JNK1, anti-RhoA, anti-Racl, anti-Cdc42, anti-RhoGDI, and anti-c-Src were purchased from Santa Cruz Laboratories, In all cases, specificity was confirmed using a battery of bacterially produced recombinant proteins (Figure 3 ; data not shown)•
